Liminatus Pharma delays quarterly report as financial statements remain incomplete
LIMN•Liminatus Pharma delayed its Form 10-Q for the quarter ended September 30, 2026, and expects to file within five calendar days of the prescribed due date.
1. Filing delay
Liminatus Pharma disclosed that it delayed its Form 10-Q because its financial statements were not completed in time to obtain the required review and signatures before the filing deadline. The company expects to file within five calendar days of the prescribed due date and does not anticipate a significant year-over-year change in operating results.




